{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:59:48Z","timestamp":1790600388718,"version":"4.1.0"},"reference-count":203,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>FOXM1, a forkhead-box transcription factor, is consistently overexpressed in breast cancer, particularly in the basal-like and triple-negative subtypes, in which high expression predicts poor survival. We propose, as a falsifiable hypothesis rather than an established mechanism, that FOXM1 may function as a dosage-integrating rheostat, in which convergent genomic, transcriptional, epitranscriptomic, translational, and post-translational inputs would determine discrete output states involving mitotic fidelity, chromosomal instability, metabolic rewiring, immune evasion, and stem-like plasticity. We further hypothesized that therapies directed elsewhere in the network are frequently buffered by the persistence or reactivation of FOXM1-associated outputs, while noting that resistance to direct FOXM1 inhibition proceeds instead through reversal of that output, which bounds the hypothesis rather than supporting it. Accordingly, we classified FOXM1-directed strategies, including direct inhibitors, degraders, condensate disruptors, upstream suppressors, and targeted delivery platforms, by their mechanism of engagement rather than by their chemical class. Existing evidence remains largely correlative and bulk-derived: available perturbation studies are categorical rather than graded, no study has titrated FOXM1 through intermediate levels or measured its outputs bidirectionally, and the few single-cell, time-resolved datasets resolve one output at a time. We identified these gaps, specified the components of an isoform-, localisation- and activation-resolved FOXM1 activity metric that would define dose in measurable terms, and proposed experiments to test threshold-dependent activation, discrete single-cell states, and history-dependent switching, grounding the last of these in the material properties and physical ageing of FOXM1 condensates rather than in an equilibrium phase boundary alone in order to distinguish dosage-dependent state selection from regulatory hub behavior.<\/jats:p>","DOI":"10.3389\/fonc.2026.1979150","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:20:16Z","timestamp":1790598016000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Ghaleb","family":"Oriquat","sequence":"first","affiliation":[{"name":"Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University","place":["Amman, Jordan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani Moslem","family":"Ahmed","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Alnoor University","place":["Nineveh, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasur","family":"Rizaev","sequence":"additional","affiliation":[{"name":"Department of Public health and Healthcare management, Rector, Samarkand State Medical University","place":["Samarkand, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamura","family":"Kucharova","sequence":"additional","affiliation":[{"name":"Department of Morphological Sciences, Termez University of Economics and Service","place":["Termez, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Polatova","sequence":"additional","affiliation":[{"name":"Scientific-Practical Medical Center for Pediatric Oncology, Hematology and Immunology","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrtda Adnan","family":"Mhysn","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, The Islamic University","place":["Najaf, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Tailor","sequence":"additional","affiliation":[{"name":"University Institute of Pharma Sciences, Chandigarh University","place":["Mohali, Punjab, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009229","article-title":"FoxM1, a forkhead transcription factor is a master cell cycle regulator for mouse mature T cells but not double positive thymocytes","volume":"5","author":"Xue","year":"2010","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.25.24.10875-10894.2005","article-title":"Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1217","article-title":"FoxM1 is required for execution of the mitotic programme and chromosome stability","volume":"7","author":"Laoukili","year":"2005","journal-title":"Nat Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ydbio.2004.08.022","article-title":"The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis","volume":"276","author":"Krupczak-Hollis","year":"2004","journal-title":"Dev Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202502016R","article-title":"FOXM1 facilitates NSCLC tumorigenesis through the transcriptional regulation of UBE2C","volume":"39","author":"Shi","year":"2025","journal-title":"FASEB J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08421-w","article-title":"Targeting FOXM1 condensates reduces breast tumour growth and metastasis","volume":"638","author":"Xie","year":"2025","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12964-025-02512-5","article-title":"Transcriptional deregulation by FOXM1-JUP signaling confers dual oncogenic drivers for pancreatic tumorigenesis and therapeutic resistance","volume":"23","author":"Yang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10585-026-10397-y","article-title":"FOXM1 expression is induced by the brain microenvironment and supports CRC brain metastatic adaptation","volume":"43","author":"Khair","year":"2026","journal-title":"Clin Exp Metastasis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210443","article-title":"Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells","volume":"26","author":"Dai","year":"2007","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111925","article-title":"PRMT5-FOXM1 axis activates \u03b2-catenin\/IL8 signaling to drive angiogenesis of gastric cancer","volume":"134","author":"Liu","year":"2025","journal-title":"Cell Signal"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-08-1968","article-title":"FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109827","article-title":"DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2012.336","article-title":"Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition","volume":"32","author":"Balli","year":"2013","journal-title":"EMBO J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218160","article-title":"Targeting FOXM1 reshapes antitumor immunity to attenuate small cell lung cancer progression","volume":"638","author":"Khan","year":"2026","journal-title":"Cancer Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-25-0605","article-title":"FOXM1-specific TCR-engineered T cells target non-small cell lung cancer","volume":"14","author":"Bontekoe","year":"2026","journal-title":"Cancer Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07420-9","article-title":"Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding ferroptosis and apoptotic cell death","volume":"208","author":"Kumar","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08321-5","article-title":"FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers","volume":"17","author":"Raghuwanshi","year":"2026","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.105289","article-title":"FOXM1-driven CKS1B upregulation promotes pancreatic cancer progression and therapeutic resistance","volume":"21","author":"Zhang","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071102","article-title":"Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1109\/tcbb.2020.2973148","article-title":"FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li","year":"2021","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2022.101693","article-title":"Exploring the prognostic significance of FOXM1 gene expression in human breast cancer by bioinformatics analysis","volume":"29","author":"Ullah","year":"2022","journal-title":"Gene Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ijo.2018.4598","article-title":"Identification of FOXM1 as a specific marker for triple-negative breast cancer","volume":"54","author":"Tan","year":"2019","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-015-3589-7","article-title":"FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index","volume":"154","author":"Yau","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223823","article-title":"Therapeutic landscape of FOXM1 in triple-negative breast cancer and aggressive solid cancers","volume":"16","author":"Dilmac","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.47","article-title":"FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance","volume":"29","author":"Millour","year":"2010","journal-title":"Oncogene"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-1-r6","article-title":"Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells","volume":"14","author":"Sanders","year":"2013","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2913","article-title":"Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3\u03b6, FOXM1, and a gene signature associated with mitosis","volume":"13","author":"Bergamaschi","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0436-4","article-title":"The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells","volume":"16","author":"Bergamaschi","year":"2014","journal-title":"Breast Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.32.19827","article-title":"Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain","volume":"272","author":"Yao","year":"1997","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1997.5065","article-title":"The human TRIDENT\/HFH-11\/FKHL16 gene: structure, localization, and promoter characterization","volume":"46","author":"Korver","year":"1997","journal-title":"Genomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbcan.2006.08.006","article-title":"FoxM1: at the crossroads of ageing and cancer","volume":"1775","author":"Laoukili","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.17.3.1626","article-title":"Hepatocyte nuclear factor 3\/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues","volume":"17","author":"Ye","year":"1997","journal-title":"Mol Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12964-018-0266-6","article-title":"Regulation of the master regulator FOXM1 in cancer","volume":"16","author":"Liao","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020251","article-title":"Pan-cancer analyses reveal genomic features of FOXM1 overexpression in cancer","volume":"11","author":"Barger","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.249","article-title":"A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-16-3566","article-title":"FOXM1 in cancer: interactions and vulnerabilities","volume":"77","author":"Gartel","year":"2017","journal-title":"Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00011","article-title":"FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c","volume":"3","author":"Lam","year":"2013","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.10.001","article-title":"A systematic screen for CDK4\/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells","volume":"20","author":"Anders","year":"2011","journal-title":"Cancer Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.2.142","article-title":"Unified nomenclature for the winged helix\/forkhead transcription factors","volume":"14","author":"Kaestner","year":"2000","journal-title":"Genes Dev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq194","article-title":"Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence","volume":"38","author":"Littler","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00881-12","article-title":"The forkhead transcription factor FOXM1 controls cell cycle-dependent gene expression through an atypical chromatin binding mechanism","volume":"33","author":"Chen","year":"2013","journal-title":"Mol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0696-z","article-title":"FOXM1 binds directly to non-consensus sequences in the human genome","volume":"16","author":"Sanders","year":"2015","journal-title":"Genome Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1101\/gad.181933.111","article-title":"The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression","volume":"26","author":"Sadasivam","year":"2012","journal-title":"Genes Dev"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw523","article-title":"Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks","volume":"44","author":"Fischer","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.24.7.2649-2661.2004","article-title":"Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300\/CBP coactivators","volume":"24","author":"Major","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01710-07","article-title":"Activation of FoxM1 during G2 requires cyclin A\/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain","volume":"28","author":"Laoukili","year":"2008","journal-title":"Mol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.46131","article-title":"An order-to-disorder structural switch activates the FoxM1 transcription factor","volume":"8","author":"Marceau","year":"2019","journal-title":"Elife"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/jci162324","article-title":"Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression","volume":"133","author":"Nandi","year":"2023","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2014.07.008","article-title":"FOXM1: A key oncofoetal transcription factor in health and disease","volume":"29","author":"Bella","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-12-0953","article-title":"FoxM1 and Wnt\/\u03b2-catenin signaling in glioma stem cells","volume":"72","author":"Gong","year":"2012","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ymthe.2019.11.027","article-title":"AAV1.SERCA2a gene therapy reverses pulmonary fibrosis by blocking the STAT3\/FOXM1 pathway and promoting the SNON\/SKI axis","volume":"28","author":"Bisserier","year":"2020","journal-title":"Mol Ther"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.534362","article-title":"Identification of maturity-onset diabetes of the young caused by mutation in FOXM1 via whole-exome sequencing in Northern China","volume":"11","author":"Zhong","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1038\/s41467-020-18276-0","article-title":"Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing","volume":"11","author":"Sawaya","year":"2020","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.01.002","article-title":"FoxM1 induces CCl2 secretion from hepatocytes triggering hepatic inflammation, injury, fibrosis, and liver cancer","volume":"9","author":"Filliol","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-1196","article-title":"The NOTCH-FOXM1 axis plays a key role in mitochondrial biogenesis in the induction of human stem cell memory-like CAR-T cells","volume":"80","author":"Kondo","year":"2020","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00151","article-title":"Estrogen receptor, inflammatory, and FOXO transcription factors regulate expression of myasthenia gravis-associated circulating microRNAs","volume":"11","author":"Fiorillo","year":"2020","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092677","article-title":"Suppression of tumor growth, metastasis, and signaling pathways by reducing FOXM1 activity in triple negative breast cancer","volume":"12","author":"Dey","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nchem.1114","article-title":"The transcription factor FOXM1 is a cellular target of the natural product thiostrepton","volume":"3","author":"Hegde","year":"2011","journal-title":"Nat Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006593","article-title":"FoxM1 is a general target for proteasome inhibitors","volume":"4","author":"Bhat","year":"2009","journal-title":"PloS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs167","article-title":"FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair","volume":"33","author":"Park","year":"2012","journal-title":"Carcinogenesis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114718","article-title":"Acyl-CoA synthetase-4 mediates radioresistance of breast cancer cells by regulating FOXM1","volume":"192","author":"Kwon","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-021-03822-5","article-title":"FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation","volume":"12","author":"Vaz","year":"2021","journal-title":"Cell Death Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41419-023-05946-2","article-title":"FOXM1 is critical for the fitness recovery of chromosomally unstable cells","volume":"14","author":"Pan","year":"2023","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246282","article-title":"Transcription regulation and genome rewiring governing sensitivity and resistance to FOXM1 inhibition in breast cancer","volume":"13","author":"Ziegler","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2020.08.016","article-title":"Metabolic imaging detects resistance to PI3K\u03b1 inhibition mediated by persistent FOXM1 expression in ER(+) breast cancer","volume":"38","author":"Ros","year":"2020","journal-title":"Cancer Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cell.2016.11.054","article-title":"Spatiotemporal control of intracellular phase transitions using light-activated optoDroplets","volume":"168","author":"Shin","year":"2017","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.047","article-title":"A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation","volume":"162","author":"Patel","year":"2015","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw4951","article-title":"Protein condensates as aging Maxwell fluids","volume":"370","author":"Jawerth","year":"2020","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41567-024-02558-1","article-title":"Sequence-specific interactions determine viscoelasticity and aging dynamics of protein condensates","volume":"20","author":"Alshareedah","year":"2024","journal-title":"Nat Phys"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01366-2","article-title":"Precise modulation of transcription factor levels identifies features underlying dosage sensitivity","volume":"55","author":"Naqvi","year":"2023","journal-title":"Nat Genet"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat Chem Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1711","article-title":"A bistable Rb-E2F switch underlies the restriction point","volume":"10","author":"Yao","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-026-00902-2","article-title":"STUB1 downregulates TOP2A through a dual mechanism of ubiquitination and FOXM1-mediated transcription repression, suppressing breast cancer growth and enhancing sensitivity to chemotherapy","volume":"31","author":"Yue","year":"2026","journal-title":"Cell Mol Biol Lett"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01339-w","article-title":"ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by increasing FOXM1 stability","volume":"31","author":"Dong","year":"2024","journal-title":"Cell Death Differ"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.41","article-title":"Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1","volume":"29","author":"Caldwell","year":"2010","journal-title":"Oncogene"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/biom13091331","article-title":"FOXM1a isoform of oncogene FOXM1 is a tumor suppressor suppressed by hnRNP C in oral squamous cell carcinoma","volume":"13","author":"Jia","year":"2023","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41419-021-03978-0","article-title":"Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells","volume":"12","author":"Chesnokov","year":"2021","journal-title":"Cell Death Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"18","DOI":"10.25259\/Cytojournal_39_2025","article-title":"Ubiquitin-specific protease 5 promotes breast cancer progression by stabilizing Forkhead box M1 through deubiquitination","volume":"23","author":"Wang","year":"2026","journal-title":"Cytojournal"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01180-7","article-title":"Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1","volume":"30","author":"Yi","year":"2023","journal-title":"Cell Death Differ"},{"key":"B81","article-title":"USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1","volume":"12","author":"Zhang","year":"2022","journal-title":"Am J Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3892\/ol.2024.14235","article-title":"OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1","volume":"27","author":"Wang","year":"2024","journal-title":"Oncol Lett"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.147275","article-title":"PSMD14 promotes breast cancer progression by reducing K63-linked ubiquitination on FOXM1 and activating the PI3K\/AKT\/mTOR pathway","volume":"327","author":"Liu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.228","article-title":"O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway","volume":"36","author":"Ferrer","year":"2017","journal-title":"Oncogene"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav6691","article-title":"Phase separation provides a mechanism to reduce noise in cells","volume":"367","author":"Klosin","year":"2020","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2256-2","article-title":"Composition-dependent thermodynamics of intracellular phase separation","volume":"581","author":"Riback","year":"2020","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biophys-121219-081629","article-title":"Physical principles underlying the complex biology of intracellular phase transitions","volume":"49","author":"Choi","year":"2020","journal-title":"Annu Rev Biophys"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0279-8","article-title":"Kinase-controlled phase transition of membraneless organelles in mitosis","volume":"559","author":"Rai","year":"2018","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13059-025-03526-5","article-title":"ASPM mediates nuclear entrapment of FOXM1 via liquid-liquid phase separation to promote progression of hepatocarcinoma","volume":"26","author":"Jiang","year":"2025","journal-title":"Genome Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03905-5","article-title":"Nucleation landscape of biomolecular condensates","volume":"599","author":"Shimobayashi","year":"2021","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202222119","article-title":"Phase-separating RNA-binding proteins form heterogeneous distributions of clusters in subsaturated solutions","volume":"119","author":"Kar","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2020.11.2012","article-title":"Chromatin mechanics dictates subdiffusion and coarsening dynamics of embedded condensates","volume":"17","author":"Lee","year":"2021","journal-title":"Nat Phys"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.126.258102","article-title":"Mechanical frustration of phase separation in the cell nucleus by chromatin","volume":"126","author":"Zhang","year":"2021","journal-title":"Phys Rev Lett"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1016\/j.cell.2024.07.034","article-title":"Condensate interfacial forces reposition DNA loci and probe chromatin viscoelasticity","volume":"187","author":"Strom","year":"2024","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14085","article-title":"Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer","volume":"595","author":"Fiscon","year":"2021","journal-title":"FEBS Lett"},{"key":"B96","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12967-024-05443-w","article-title":"CDCA5 accelerates progression of breast cancer by promoting the binding of E2F1 and FOXM1","volume":"22","author":"Xiong","year":"2024","journal-title":"J Transl Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217423","article-title":"Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53\/E2F1\/FOXM1-axis","volume":"611","author":"Jia","year":"2024","journal-title":"Cancer Lett"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/cells14161235","article-title":"Identification of epigenetic regulatory networks of gene methylation-miRNA-transcription factor feed-forward loops in basal-like breast cancer","volume":"14","author":"Okano","year":"2025","journal-title":"Cells"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092689","article-title":"RASSF1A suppresses estrogen-dependent breast cancer cell growth through inhibition of the Yes-associated protein 1 (YAP1), inhibition of the Forkhead box protein M1 (FOXM1), and activation of Forkhead box transcription factor 3A (FOXO3A)","volume":"12","author":"Ro\u00dfwag","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00438.2024","article-title":"FOXM1 cooperates with ER\u03b1 to regulate functional \u03b2-cell mass","volume":"328","author":"Peng","year":"2025","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B101","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41598-024-85100-w","article-title":"A computational and structural approach to identify malignant non-synonymous FOXM1 single nucleotide polymorphisms in triple-negative breast cancer","volume":"15","author":"Chatterjee","year":"2025","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27021052","article-title":"Time-dependent loss of miR-548c-3p and activation of E2F3\/FOXM1 in breast cancer: In vitro and TCGA-based evidence for a post-transcriptional mechanism","volume":"27","author":"Bozkurt","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1131433","article-title":"MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer","volume":"10","author":"Kuthethur","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.109979","article-title":"MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer","volume":"83","author":"Hamurcu","year":"2021","journal-title":"Cell Signal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5559","article-title":"Lnc-RGS5 sponges miR-542-5p to promote FoxM1\/VEGFA signaling and breast cancer cell proliferation","volume":"63","author":"Song","year":"2023","journal-title":"Int J Oncol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12935-021-02316-w","article-title":"CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-022-00759-w","article-title":"YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner","volume":"12","author":"Chen","year":"2022","journal-title":"Cell Biosci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16137","article-title":"YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer","volume":"115","author":"Shen","year":"2024","journal-title":"Cancer Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1210-y","article-title":"Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer","volume":"39","author":"Gong","year":"2020","journal-title":"Oncogene"},{"key":"B110","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13058-023-01675-8","article-title":"Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer","volume":"25","author":"Katzenellenbogen","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.11.007","article-title":"A genomic and functional inventory of deubiquitinating enzymes","volume":"123","author":"Nijman","year":"2005","journal-title":"Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1261\/rna.042838.113","article-title":"The crystal structure of S. cerevisiae Sad1, a catalytically inactive deubiquitinase that is broadly required for pre-mRNA splicing","volume":"20","author":"Hadjivassiliou","year":"2014","journal-title":"Rna"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.17.6553","article-title":"Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B","volume":"7","author":"van Leuken","year":"2008","journal-title":"Cell Cycle"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.10.2553","article-title":"The 65 and 110 kDa SR-related proteins of the U4\/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes","volume":"20","author":"Makarova","year":"2001","journal-title":"EMBO J"},{"key":"B115","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41419-021-03581-3","article-title":"Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1042\/bst20160268","article-title":"Pseudo-DUBs as allosteric activators and molecular scaffolds of protein complexes","volume":"46","author":"Walden","year":"2018","journal-title":"Biochem Soc Trans"},{"key":"B117","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41467-025-67083-y","article-title":"Metabolic syndrome promotes endometrial cancer by Oleic acid-mediated polyamine accumulation","volume":"17","author":"Zhai","year":"2025","journal-title":"Nat Commun"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081810","article-title":"Functional characterization of circulating tumor cells (CTCs) from metastatic ER+\/HER2- breast cancer reveals dependence on HER2 and FOXM1 for endocrine therapy resistance and tumor cell survival: Implications for treatment of ER+\/HER2- breast cancer","volume":"13","author":"Ro\u00dfwag","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7672","article-title":"FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells","volume":"7","author":"Hamurcu","year":"2016","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3661","article-title":"AKT\/FOXM1\/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer","volume":"26","author":"Li","year":"2024","journal-title":"J Gene Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-022-02373-7","article-title":"Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt\/\u03b2-catenin pathway","volume":"41","author":"Li","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041823","article-title":"FOXM1 signaling network transcriptionally upregulates expression of proteins involved in mitotic progression to induce high proliferation and chromosomal instability in androgen receptor-low triple-negative breast cancer","volume":"27","author":"Rida","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10735-025-10674-2","article-title":"FOXM1\/FUS facilitates triple-negative breast cancer malignant progression and glutamine metabolism through mediating SLC7A5 transcription","volume":"57","author":"Li","year":"2026","journal-title":"J Mol Histol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217612","article-title":"SLC7A5\/E2F1\/PTBP1\/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway","volume":"617","author":"Jiang","year":"2025","journal-title":"Cancer Lett"},{"key":"B125","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00432-025-06174-1","article-title":"FOXM1 boosts glycolysis by upregulating SQLE to inhibit anoikis in breast cancer cells","volume":"151","author":"Xu","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413103","article-title":"Dual inhibition of CDK4\/6 and CDK7 suppresses triple-negative breast cancer progression via epigenetic modulation of SREBP1-regulated cholesterol metabolism","volume":"12","author":"Yang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00032.2024","article-title":"Forkhead box M1 mediates metabolic reprogramming in human colorectal cancer cells","volume":"327","author":"Li","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101033","article-title":"Squalene monooxygenase: a journey to the heart of cholesterol synthesis","volume":"79","author":"Chua","year":"2020","journal-title":"Prog Lipid Res"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.774471","article-title":"Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements","volume":"292","author":"Mookerjee","year":"2017","journal-title":"J Biol Chem"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2014.10.005","article-title":"The contributions of respiration and glycolysis to extracellular acid production","volume":"1847","author":"Mookerjee","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: A central metabolic enzyme in cancer","volume":"471","author":"Icard","year":"2020","journal-title":"Cancer Lett"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2011.76.010868","article-title":"Control of glycolysis through regulation of PFK1: old friends and recent additions","volume":"76","author":"Mor","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature13236","article-title":"Quantitative flux analysis reveals folate-dependent NADPH production","volume":"510","author":"Fan","year":"2014","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1042\/bj20031186","article-title":"Methyl-beta-cyclodextrin stimulates glucose uptake in Clone 9 cells: a possible role for lipid rafts","volume":"378","author":"Barnes","year":"2004","journal-title":"Biochem J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041246","article-title":"Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells","volume":"7","author":"Caliceti","year":"2012","journal-title":"PloS One"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217586","article-title":"SQLE-catalyzed squalene metabolism promotes mitochondrial biogenesis and tumor development in K-ras-driven cancer","volume":"616","author":"Pan","year":"2025","journal-title":"Cancer Lett"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0945-5","article-title":"Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death","volume":"567","author":"Garcia-Bermudez","year":"2019","journal-title":"Nature"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/srep19435","article-title":"Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer","volume":"6","author":"Brown","year":"2016","journal-title":"Sci Rep"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/bph.70330","article-title":"Reprogramming tumour-associated macrophages in breast cancer via si-FOXM1-loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy","volume":"183","author":"Gao","year":"2026","journal-title":"Br J Pharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1266\/ggs.24-00079","article-title":"FOXM1 derived from triple-negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of tumor-associated macrophages","volume":"100","author":"Wang","year":"2025","journal-title":"Genes Genet Syst"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01755-w","article-title":"Macrophage polarization-based analysis of the role of the FOXM1\/KIF20A axis in breast cancer metastasis","volume":"83","author":"Wang","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"B143","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1038\/s41467-025-59186-3","article-title":"Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory","volume":"16","author":"Timilsina","year":"2025","journal-title":"Nat Commun"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008923","article-title":"Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression","volume":"13","author":"Tang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-0410","article-title":"Transcriptional repression by FoxM1 suppresses tumor differentiation and promotes metastasis of breast cancer","volume":"82","author":"Kopanja","year":"2022","journal-title":"Cancer Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108349","article-title":"FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner","volume":"685","author":"Sun","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-07102-5","article-title":"FOXM1 mediates GDF-15 dependent stemness and intrinsic drug resistance in breast cancer","volume":"49","author":"Modi","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119408","article-title":"Dandelion extract suppresses the stem-like properties of triple-negative breast cancer cells by regulating CUEDC2\/\u03b2-catenin\/OCT4 signaling axis","volume":"342","author":"Deng","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-024-10267-5","article-title":"CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway","volume":"55","author":"Yang","year":"2024","journal-title":"J Mol Histol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41416-025-03074-6","article-title":"Wnt\/ERK\/CDK4\/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation","volume":"133","author":"Liang","year":"2025","journal-title":"Br J Cancer"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.94.128701","article-title":"Cell fates as high-dimensional attractor states of a complex gene regulatory network","volume":"94","author":"Huang","year":"2005","journal-title":"Phys Rev Lett"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03796-6","article-title":"Cycling cancer persister cells arise from lineages with distinct programs","volume":"596","author":"Oren","year":"2021","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328698","article-title":"Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression","volume":"20","author":"Li","year":"2025","journal-title":"PloS One"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1530\/erc-20-0258","article-title":"Amphiregulin retains ER\u03b1 expression in acquired aromatase inhibitor resistant breast cancer cells","volume":"27","author":"Wang","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"B156","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41523-025-00752-9","article-title":"The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA\/PTEN altered estrogen receptor positive breast cancer","volume":"11","author":"Cutano","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03238-3","article-title":"Reversal of endocrine resistance via N6AMT1-NEDD4L pathway-mediated p110\u03b1 degradation","volume":"44","author":"Ji","year":"2025","journal-title":"Oncogene"},{"key":"B158","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-9296085\/v1","article-title":"Flavopiridol inhibits FOXM1\/NF-kB and KRAS\/MAPK signaling and DNA repair mechanims and Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin the","author":"Metin","year":""},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050672","article-title":"Morin sensitizes MDA-MB-231 triple-negative breast cancer cells to doxorubicin cytotoxicity by suppressing FOXM1 and attenuating EGFR\/STAT3 signaling pathways","volume":"16","author":"Maharjan","year":"2023","journal-title":"Pharm (Basel)"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00835","article-title":"Maslinic acid enhances docetaxel response in human docetaxel-resistant triple negative breast carcinoma MDA-MB-231 cells via regulating MELK-foxM1-ABCB1 signaling cascade","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1038\/s41598-021-82990-y","article-title":"BKM120 sensitizes BRCA-proficient triple negative breast cancer cells to olaparib through regulating FOXM1 and Exo1 expression","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41419-021-04434-9","article-title":"FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-026-01360-x","article-title":"BET inhibition disrupts the FOXM1-MYC axis to induce BRCAness and enhance PARP inhibitor response","volume":"10","author":"Fang","year":"2026","journal-title":"NPJ Precis Oncol"},{"key":"B164","article-title":"Association between FOXM1 and PLK1 expression in response to CDK4\/6 inhibitor drugs in breast cancer cells","volume-title":"Health Biotechnology and Biopharma (HBB)","author":"Shahbazi","year":"2026"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-026-00911-6","article-title":"JAK\/STAT1-interferon-ISGylation networks in breast cancer resistance to inhibitors of FOXM1 and CDK4\/6","volume":"12","author":"Ziegler","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-06068-5","article-title":"FOXA1 is a determinant of drug resistance in breast cancer cells","volume":"186","author":"Kumar","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040756","article-title":"The promise of combination therapies with FOXM1 inhibitors for cancer treatment","volume":"16","author":"Merjaneh","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189015","article-title":"Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments","volume":"1878","author":"Raghuwanshi","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-06878-3","article-title":"Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs","volume":"198","author":"Guillen","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"B170","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/ncomms6165","article-title":"Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition","volume":"5","author":"Gormally","year":"2014","journal-title":"Nat Commun"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136685","article-title":"The anticancer effects of FDI-6, a FOXM1 inhibitor, on triple negative breast cancer","volume":"22","author":"Ulhaka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2025-1753","article-title":"A novel FOXM1 inhibitor inhibits FOXM1 cell proliferation, migration, and invasion tumor growth in triple negative breast cancer","volume":"85","author":"Dilmac","year":"2025","journal-title":"Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41420-024-01929-0","article-title":"Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies","volume":"10","author":"Raghuwanshi","year":"2024","journal-title":"Cell Death Discov"},{"key":"B174","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12032-024-02427-0","article-title":"A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells","volume":"41","author":"Abusharkh","year":"2024","journal-title":"Med Oncol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41397-022-00297-1","article-title":"Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer","volume":"23","author":"Huang","year":"2023","journal-title":"Pharmacogenomics J"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70296","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of novel 2-aminothiazole derivatives as potential FOXM1 inhibitors for triple-negative breast cancer therapy and structure-activity relationship","volume":"87","author":"Abusharkh","year":"2026","journal-title":"Drug Dev Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13578-023-01059-7","article-title":"The development of an anti-cancer peptide M1-21 targeting transcription factor FOXM1","volume":"13","author":"Cheng","year":"2023","journal-title":"Cell Biosci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-022-02483-2","article-title":"Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03119-9","article-title":"EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth","volume":"43","author":"Corbin","year":"2024","journal-title":"Oncogene"},{"key":"B180","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41580-020-00326-6","article-title":"Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing","volume":"22","author":"Alberti","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.003","article-title":"Biomolecular condensates and cancer","volume":"39","author":"Boija","year":"2021","journal-title":"Cancer Cell"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010470","article-title":"Apigenin, a partial antagonist of the estrogen receptor (ER), inhibits ER-positive breast cancer cell proliferation through akt\/FOXM1 signaling","volume":"22","author":"Pham","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2023.9665","article-title":"Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT\/FOXO3\/FOXM1 axis in breast cancer cells","volume":"24","author":"Li","year":"2024","journal-title":"Biomol BioMed"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899402","article-title":"Andrographolide inhibits ER-positive breast cancer growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-\u03b1 Axis","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1142\/s0192415x21500221","article-title":"Mistletoe extract targets the STAT3-FOXM1 pathway to induce apoptosis and inhibits metastasis in breast cancer cells","volume":"49","author":"Kwon","year":"2021","journal-title":"Am J Chin Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8316","article-title":"Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway","volume":"47","author":"Tsao","year":"2022","journal-title":"Oncol Rep"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-08-0805","article-title":"Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer","volume":"8","author":"McGovern","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-023-01495-5","article-title":"Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo","volume":"14","author":"Masoudi","year":"2024","journal-title":"Drug Delivery Transl Res"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118520","article-title":"Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo","volume":"262","author":"Ghandhariyoun","year":"2020","journal-title":"Life Sci"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2023.71129.15452","article-title":"Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers","volume":"26","author":"Abdollahzade","year":"2023","journal-title":"Iran J Basic Med Sci"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2024.2404979","article-title":"TGF-\u03b21 and FOXM1 siRNA co-loaded nanoparticles by disulfide crosslinked PEG-PDMAEMA for the treatment of triple-negative breast cancer and its bone metastases in vitro","volume":"50","author":"Wang","year":"2024","journal-title":"Drug Dev Ind Pharm"},{"key":"B192","first-page":"102521","article-title":"A novel targeted co-delivery system for transfer of epirubicin and antimiR-10b into cancer cells through a linear DNA nanostructure consisting of FOXM1 and AS1411 aptamers","volume-title":"Journal of Drug Delivery Science and Technology","author":"Yaghoobi","year":"2021"},{"key":"B193","article-title":"Multifunctional responsive nanoplatform as immunotherapeutic regulator to target triple\u2010Negative breast cancers via mechanotransduction","volume-title":"Advanced Functional Materials","author":"Li","year":"2026"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101493","article-title":"M1-NP1 interfering-peptide inhibits cancer cell proliferation and migration by targeting the transcription factor FOXM1","volume":"16","author":"Pei","year":"2026","journal-title":"J Pharm Anal"},{"key":"B195","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.copbio.2015.02.003","article-title":"A roadmap for interpreting (13)C metabolite labeling patterns from cells","volume":"34","author":"Buescher","year":"2015","journal-title":"Curr Opin Biotechnol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/nature08268","article-title":"Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment","volume":"461","author":"Schafer","year":"2009","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0414-6","article-title":"RNA velocity of single cells","volume":"560","author":"La Manno","year":"2018","journal-title":"Nature"},{"key":"B198","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.cell.2019.01.006","article-title":"Optimal-transport analysis of single-cell gene expression identifies developmental trajectories in reprogramming","volume":"176","author":"Schiebinger","year":"2019","journal-title":"Cell"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202110282","article-title":"RNA velocity-current challenges and future perspectives","volume":"17","author":"Bergen","year":"2021","journal-title":"Mol Syst Biol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2019.08.030","article-title":"Quantifying dynamics in phase-separated condensates using fluorescence recovery after photobleaching","volume":"117","author":"Taylor","year":"2019","journal-title":"Biophys J"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3958","article-title":"Coactivator condensation at super-enhancers links phase separation and gene control","volume":"361","author":"Sabari","year":"2018","journal-title":"Science"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cell.2018.10.048","article-title":"Mapping local and global liquid phase behavior in living cells using photo-oligomerizable seeds","volume":"175","author":"Bracha","year":"2018","journal-title":"Cell"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.21037\/atm-21-5271","article-title":"A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1979150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:20:19Z","timestamp":1790598019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1979150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":203,"alternative-id":["10.3389\/fonc.2026.1979150"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1979150","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1979150"}}